YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Yarrow Bioscience, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$19.98+1.67 (+9.12%)
Close on Oct 19, 2026
- Market cap
- $17.14M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 13, 2026(first seen in filings) | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Jul 27, 2026 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Feb 13, 2023 | 1-for-18 reverse | Earlier per-share figures multiplied by 18 |
| Feb 10, 2023 | 1-for-18 reverse | Earlier per-share figures multiplied by 18 |
| Feb 16, 2021 | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Feb 12, 2021 | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |